199 related articles for article (PubMed ID: 12631116)
1. Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy.
van der Boog PJ; De Fijter JW; Van Kooten C; Van Der Holst R; Van Seggelen A; Van Es LA; Daha MR
Kidney Int; 2003 Feb; 63(2):514-21. PubMed ID: 12631116
[TBL] [Abstract][Full Text] [Related]
2. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333
[TBL] [Abstract][Full Text] [Related]
3. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
4. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
5. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition.
van der Boog PJ; van Kooten C; van Zandbergen G; Klar-Mohamad N; Oortwijn B; Bos NA; van Remoortere A; Hokke CH; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Nov; 19(11):2729-36. PubMed ID: 15340093
[TBL] [Abstract][Full Text] [Related]
6. Reduced binding of immunoglobulin A (IgA) from patients with primary IgA nephropathy to the myeloid IgA Fc-receptor, CD89.
van Zandbergen G; van Kooten C; Mohamad NK; Reterink TJ; de Fijter JW; van de Winkel JG; Daha MR
Nephrol Dial Transplant; 1998 Dec; 13(12):3058-64. PubMed ID: 9870466
[TBL] [Abstract][Full Text] [Related]
7. Fc alpha RI/CD89 circulates in human serum covalently linked to IgA in a polymeric state.
van der Boog PJ; van Zandbergen G; de Fijter JW; Klar-Mohamad N; van Seggelen A; Brandtzaeg P; Daha MR; van Kooten C
J Immunol; 2002 Feb; 168(3):1252-8. PubMed ID: 11801662
[TBL] [Abstract][Full Text] [Related]
8. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
9. Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History.
Wu H; Wang X; Yang Z; Zhao Q; Wen Y; Li X; Zhang W; Gao R
Dis Markers; 2020; 2020():8393075. PubMed ID: 32076466
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy.
Jhee JH; Kang HY; Wu M; Nam BY; Chang TI; Jung SY; Park S; Kim H; Yun HR; Kee YK; Yoon CY; Park JT; Yoo TH; Kang SW; Han SH
Clin Chem Lab Med; 2017 Nov; 56(1):75-85. PubMed ID: 28672768
[TBL] [Abstract][Full Text] [Related]
11. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
12. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
13. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
Launay P; Grossetête B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC
J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814
[TBL] [Abstract][Full Text] [Related]
14. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
[TBL] [Abstract][Full Text] [Related]
16. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
17. Expression and correlation analysis of IL-4, IFN-γ and FcαRI in tonsillar mononuclear cells in patients with IgA nephropathy.
Chen X; Liu H; Peng Y; He L; Zhang Y; Xie Y; Peng X; Liu C; Liu F
Cell Immunol; 2014; 289(1-2):70-5. PubMed ID: 24732061
[TBL] [Abstract][Full Text] [Related]
18. Role of macromolecular IgA in IgA nephropathy.
van der Boog PJ; van Kooten C; de Fijter JW; Daha MR
Kidney Int; 2005 Mar; 67(3):813-21. PubMed ID: 15698421
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of IgA receptors in IgA nephropathy.
Monteiro RC
Contrib Nephrol; 2007; 157():64-9. PubMed ID: 17495439
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic significance of IgA receptor interactions in IgA nephropathy.
Monteiro RC; Moura IC; Launay P; Tsuge T; Haddad E; Benhamou M; Cooper MD; Arcos-Fajardo M
Trends Mol Med; 2002 Oct; 8(10):464-8. PubMed ID: 12383768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
